# BEGAIN

## Overview
The BEGAIN gene encodes the brain enriched guanylate kinase-associated protein, which is primarily involved in synaptic function and neuronal signaling within the brain. This protein is a component of the post-synaptic density (PSD) and interacts with key synaptic proteins, such as PSD-95 and NMDA receptors, playing a crucial role in synaptic plasticity and neurotransmitter receptor regulation (Katano2023Brainenricheda; Katano2023Brainenriched). Beyond its neurological functions, BEGAIN is expressed in various muscle-related cell types, indicating its involvement in muscle cell development and differentiation (Dastsooz2024Involvement). Clinically, BEGAIN has been implicated in several cancers, including breast cancer, where its downregulation is associated with disease progression, suggesting a potential role as a tumor suppressor and prognostic biomarker (Dastsooz2024Involvement).

## Structure


## Function
The BEGAIN gene encodes a protein that plays a significant role in synaptic function and neuronal signaling, primarily within the brain. It is involved in the regulation of postsynaptic neurotransmitter receptor activity and the modulation of chemical synaptic transmission, which are crucial for maintaining synaptic structure and function (Dastsooz2024Involvement). BEGAIN is important in neuromuscular junctions (NMJs), which are synapses between motor neurons and skeletal muscle fibers, indicating its role in the regulation of nervous system processes (Dastsooz2024Involvement).

In addition to its neurological functions, BEGAIN is expressed in various cell types within breast tissue, including fibroblasts and mesenchymal cells, suggesting a role in muscle cell development and differentiation (Dastsooz2024Involvement). The gene is expressed at higher levels in muscle cells compared to human embryonic stem cells, indicating its involvement in muscle differentiation (Dastsooz2024Involvement). BEGAIN's expression in mesenchymal cells, breast myoepithelial cells, and smooth muscle cells further supports its role in muscle cell processes (Dastsooz2024Involvement). These functions highlight BEGAIN's involvement in both synaptic and muscle cell biology, contributing to its potential roles in various physiological processes.

## Clinical Significance
The BEGAIN gene has been implicated in various cancers, particularly breast cancer, where it is significantly downregulated compared to normal tissues. This downregulation is consistent across different tumor stages and breast cancer subclasses, including luminal types, HER2-positive, and triple-negative breast cancers, with the lowest expression observed in HER2-positive subclasses (Dastsooz2024Involvement). The decreased expression of BEGAIN is also noted in other cancers such as uterine, stomach, prostate, colon, bladder, thyroid, kidney, and brain cancers, suggesting a broader role in tumorigenesis and metastasis (Dastsooz2024Involvement).

In breast cancer patients, low BEGAIN expression is associated with a higher risk of the disease, particularly in those with conditions like high blood fat, heart problems, and diabetes (Dastsooz2024Involvement). The gene's downregulation in breast cancer tissues suggests it may function as a tumor suppressor, and its expression levels could serve as a prognostic biomarker, especially for HER2-positive breast cancer (Dastsooz2024Involvement). BEGAIN's involvement in muscle cell development and its expression in various cell types further indicate its potential role in muscle-related disorders (Dastsooz2024Involvement).

## Interactions
BEGAIN, a component of the post-synaptic density (PSD) protein complexes, is involved in several protein interactions crucial for synaptic function. It interacts with the guanylate kinase (GK) domain of PSD-95, a major scaffold protein in the PSD, suggesting its role in complex formation within the PSD (Katano2023Brainenricheda; Katano2023Brainenriched). This interaction is similar to that of GKAP, another PSD protein, indicating that BEGAIN is a significant component of the PSD protein complex (Katano2023Brainenriched). BEGAIN forms a homodimer in its N-terminal region and interacts with PSD-95 in its C-terminal region, which is essential for its localization and function at glutamatergic synapses (Katano2023Brainenricheda).

BEGAIN also functionally interacts with N-methyl-D-aspartate (NMDA) receptors, including the GluN2B subunit, which is involved in synaptic plasticity and neuropathic pain (Katano2023Brainenricheda). The interaction with NMDA receptors suggests that BEGAIN may play a role in modulating synaptic transmission and plasticity through NMDAR-related pathways (Katano2023Brainenricheda). These interactions highlight BEGAIN's involvement in synaptic signaling and its potential impact on learning and memory processes.


## References


1. (Katano2023Brainenriched) Brain-enriched guanylate kinase-associated protein (BEGAIN), a component of the post-synaptic density protein complexes, contributes to physiological plasticity, learning and memory. This article has 0 citations.

[2. (Katano2023Brainenricheda) Tayo Katano, Kohtarou Konno, Keizo Takao, Manabu Abe, Akari Yoshikawa, Tsuyoshi Miyakawa, Kenji Sakimura, Masahiko Watanabe, Seiji Ito, and Takuya Kobayashi. Brain-enriched guanylate kinase-associated protein, a component of the post-synaptic density protein complexes, contributes to learning and memory. Scientific Reports, December 2023. URL: http://dx.doi.org/10.1038/s41598-023-49537-9, doi:10.1038/s41598-023-49537-9. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-023-49537-9)

[3. (Dastsooz2024Involvement) Hassan Dastsooz, Francesca Anselmi, Andrea Lauria, Chiara Cicconetti, Valentina Proserpio, Elham Mohammadisoleimani, Zahra Firoozi, Yaser Mansoori, Hamed Haghi-Aminjan, Livia Caizzi, and Salvatore Oliviero. Involvement of n4bp2l1, plekha4, and begain genes in breast cancer and muscle cell development. Frontiers in Cell and Developmental Biology, May 2024. URL: http://dx.doi.org/10.3389/fcell.2024.1295403, doi:10.3389/fcell.2024.1295403. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2024.1295403)